0000899243-19-020992.txt : 20190805
0000899243-19-020992.hdr.sgml : 20190805
20190805161650
ACCESSION NUMBER: 0000899243-19-020992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190801
FILED AS OF DATE: 20190805
DATE AS OF CHANGE: 20190805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith W Bradford
CENTRAL INDEX KEY: 0001317678
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 19998836
MAIL ADDRESS:
STREET 1: C/O HOMOLOGY MEDICINES, INC.
STREET 2: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Homology Medicines, Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-301-7277
MAIL ADDRESS:
STREET 1: ONE PATRIOTS PARK
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-01
0
0001661998
Homology Medicines, Inc.
FIXX
0001317678
Smith W Bradford
C/O HOMOLOGY MEDICINES, INC.
ONE PATRIOTS PARK
BEDFORD
MA
01730
0
1
0
0
CFO, Treasurer & Secretary
Common Stock
2019-08-01
4
M
0
6000
0.64
A
6000
D
Common Stock
2019-08-01
4
S
0
6000
17.3651
D
0
D
Employee Stock Option
0.64
2019-08-01
4
M
0
6000
0.00
D
2027-04-05
Common Stock
6000
145404
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $16.73 to $17.68. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017.
/s/ W. Bradford Smith
2019-08-05